MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
APRE — Aprea Therapeutics, Inc. Common stock
NasdaqAprea Therapeutics, Inc. Common stock
$0.70
-0.03(-3.94%)
- O
- 0.72
- H
- 0.74
- L
- 0.69
- V
- 862.19K
⏱️ End-of-day dataAs of Oct 2, 2026
APRE — Latest News & Headlines
5 StoriesWall Street’s Nasdaq hits all-time high as AI frenzy gathers pace - Al Jazeera
Wall Street’s Nasdaq hits all-time high as AI frenzy gathers pace Al Jazeera
What Is Asset Tokenization? Meaning, Examples, Pros, & Cons - Britannica
What Is Asset Tokenization? Meaning, Examples, Pros, & Cons Britannica
CDT Equity Inc. (CDT) stock price, news, quote and history - Yahoo Finance Singapore
CDT Equity Inc. (CDT) stock price, news, quote and history Yahoo Finance Singapore
Aprea Therapeutics to present WEE1 inhibitor trial data in November By Investing.com - Investing.com India
Aprea Therapeutics to present WEE1 inhibitor trial data in November By Investing.com Investing.com India
Lunai Bioworks (LNAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lunai Bioworks (LNAI) Stock Analysis Report | Ratings, Financials & Performance Benzinga